# Tango Therapeutics Inc. (TNGX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$111M |
| 2024 | -$146M |
| 2023 | -$114M |
| 2022 | -$111M |
| 2021 | -$58M |
| 2020 | -$52M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$49M |
| 2025-09-30 | $14M |
| 2025-06-30 | -$41M |
| 2025-03-31 | -$43M |
| 2024-09-30 | -$33M |
| 2024-06-30 | -$30M |
| 2024-03-31 | -$42M |
| 2023-09-30 | -$26M |
| 2023-06-30 | -$23M |
| 2023-03-31 | -$30M |
| 2022-09-30 | -$30M |
| 2022-06-30 | -$25M |
| 2022-03-31 | -$25M |
| 2021-09-30 | -$20M |
| 2021-06-30 | -$5M |
| 2021-03-31 | -$12M |
| 2020-09-30 | -$27M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/TNGX/operating-income)